Question 1

Who are the top researchers at MaxCyte (United States)?

Accepted Answer

Ranked on the quality score, Linda N. Liu, Madhusudan V. Peshwa and Linhong Li lead among researchers whose main affiliation is MaxCyte (United States).

Question 2

What are the most cited papers from MaxCyte (United States)?

Accepted Answer

The most cited paper from MaxCyte (United States) is "CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease" (Suk See De Ravin, Linhong Li, Xiaolin Wu et al., 2017), with 262 citations. Next come "Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease" (195) and "Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method" (141).

Question 3

Which research topics does MaxCyte (United States) publish most on?

Accepted Answer

By volume in 2022-now: CRISPR and Genetic Engineering, CAR-T cell therapy research, Virus-based gene therapy research and Viral Infectious Diseases and Gene Expression in Insects.

Question 4

Which keywords describe research at MaxCyte (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Gene Therapy, Immunotherapy, Lymphoma, Leukemia, Tumor Regression, CAR T Cells and Chimeric Antigen Receptor.

Question 5

Which fields of science does MaxCyte (United States) work in?

Accepted Answer

In all years, 62% of research at MaxCyte (United States) is in Life Sciences, 30% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (46%), Medicine (30%), Immunology and Microbiology (15%). It does 3.0× the world's share of Life Sciences.

Question 6

Is MaxCyte (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 32% lower than in 2018-2021.